Archive for June 6th, 2022

Dostarlimab 

Monday, June 6th, 2022

18 rectal cancer patients were given dostarlimab every three weeks for six months and ended up cancer-free………………………….“I believe this is the first time this has happened in the history of cancer………”

(more…)